Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,610 across all filing types
Latest filing 2023-10-03 Regulatory Filings
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities, specifically detailing movements in authorised/registered share capital and issued shares for Sinopharm Group Co. Ltd. It includes confirmations related to securities issuance and compliance with listing rules. The document is structured as a regulatory return with no financial statements or management discussion. It is not an annual or interim report, earnings release, or any form of shareholder meeting material. It is a regulatory filing reporting share capital and share issuance movements as required by the exchange rules. Therefore, it fits best under Regulatory Filings (RNS).
2023-10-03 English
Notification Letter with Request Form to Non-Registered Shareholders
Report Publication Announcement Classification · 95% confidence The document is a notification letter from Sinopharm Group Co. Ltd. dated 25 September 2023, informing non-registered shareholders about the publication of the company's 2023 Interim Report. It provides instructions on how shareholders can access the report online or request printed copies. The document includes a request form for shareholders to choose their preferred method of receiving future corporate communications. The text explicitly states that the "Current Corporate Communication" refers to the 2023 Interim Report. However, the document itself does not contain the actual interim report or substantive financial data; it only announces the publication and availability of the report. The document length is 8462 characters, which is relatively short and consistent with an announcement rather than a full report. According to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA) because it announces the availability of the interim report but does not include the report itself.
2023-09-25 English
Notification Letter with Request Form to Registered Shareholders
Report Publication Announcement Classification · 100% confidence The document is a notification letter from Sinopharm Group Co. Ltd. dated 25 September 2023, informing shareholders about the publication of the company's 2023 Interim Report. It provides instructions on how shareholders can access the report online or request a printed copy. The document does not contain the actual interim financial statements or substantive financial data but serves as a notice of the report's availability. The document length is 8369 characters, which is relatively short and consistent with a notification rather than a full report. According to the 'MENU VS MEAL' rule, this is an announcement of the report publication, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2023-09-25 English
Interim Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2023' and contains detailed sections such as Management Discussion and Analysis, Interim Condensed Consolidated Financial Statements, Notes to the Interim Condensed Consolidated Financial Information, and other comprehensive financial and operational data. The reporting period is explicitly stated as the six months ended 30 June 2023. The length of the document is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes financial statements and detailed analysis, which aligns with the characteristics of an Interim / Quarterly Report. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2023
2023-09-25 English
List of Directors and Their Role and Function
Board/Management Information Classification · 100% confidence The document is a formal announcement listing the members of the board of directors and their roles and functions, including details about board committees and their memberships. It does not contain financial data, earnings, or report content. It is not a report itself but an announcement related to the company's board structure and management. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming it is not an annual report or other financial filing.
2023-09-15 English
ANNOUNCEMENT (1) POLL RESULTS OF THE EGM HELD ON FRIDAY, 15 SEPTEMBER 2023&#x3b; (2) ELECTION OF CHAIRMAN AND VICE CHAIRMAN OF THE BOARD, AND CHAIRMEN AND MEMBERS OF THE SPECIAL COMMITTEES OF THE BOAR
Board/Management Information Classification · 95% confidence The document is an announcement from Sinopharm Group Co. Ltd. regarding the poll results of an Extraordinary General Meeting (EGM) held on 15 September 2023. It details the election of the chairman and vice chairman of the board, as well as the chairmen and members of various board committees. The content focuses on voting results and board/committee appointments, which are typical of announcements related to board or management changes. There is no indication of financial data, audit information, or report publication. The document is lengthy and detailed, not a brief notice or a certification. Therefore, the document fits best under the category of Board/Management Information (MANG).
2023-09-15 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.